DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Sawaki M, Saito T, Baba S. et al.
Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT).
J Clin Oncol 2018;
36 (Suppl.) Abstr.. 510
We do not assume any responsibility for the contents of the web pages of other providers.